The new plant will give Novartis end-to-end capabilities centered on North Carolina, where it plans to have five facilities ...
Novartis will construct an active pharmaceutical ingredient (API) facility in Morrisville, North Carolina, the company said ...
Novartis has finalized its $23 billion U.S. manufacturing and R&D expansion with plans for a new active pharmaceutical ingredient facility in Morrisville, North Carolina. The 56,200-square-foot site ...
CDMO company Cambrex completed the second phase of an expansion at its Snapdragon Chemistry API production facility in Waltham, Massachusetts. The project added 51,000 square feet to the facility’s ...
In this interview, NewsMed talks to Dr. James Mencel's Guidance about Scaling Up API Processes. Could you introduce yourself and your experience in the pharmaceutical industry? I obtained a B.S. in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results